Lannett reported $100.44M in Operating Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbvie ABBV:US $ 11288M 2467M
Amerisourcebergen ABC:US $ 59523.1M 2583.82M
Ani Pharmaceuticals ANIP:US $ 86.77M 3.1M
Aurora Cannabis Inc ACB:CN 1.05B 921.9M
Canopy Growth Corp WEED:CN C$ 1.95B 1.3B
Cardinal Health CAH:US 47.07B 2.13B
Corcept Therapeutics CORT:US $ 71.95M 5.04M
Depomed DEPO:US $ 24.34M 639K
JAZZ PHA JAZZ:US $ 847.33M 121.16M
Knight Therapeutics Inc GUD:CN C$ 72.93M 9.08M
Lannett LCI:US $ 100.44M 54.15M
Ligand Pharmaceuticals LGND:US $ 57.89M 4.39M
Mckesson MCK:US $ 66118M 649M
Nektar Therapeutics NKTR:US $ 174.42M 33.04M
Novartis NVS:US 10.86B 895M
Pacira Pharmaceuticals PCRX:US $ 138.18M 2.42M
Perrigo Ordinary Shares PRGO:US $ 1137.9M 85.1M
Pfizer PFE:US $ 15640M 148M
Phibro Animal Health PAHC:US $ 220.42M 10.01M
Prestige Brands PBH:US $ 190.04M 534K
Supernus Pharmaceuticals SUPN:US $ 158.7M 8.17M
Teva Pharmaceutical TEVA:IT 4.74B 361M
Zoetis ZTS:US $ 1.38B 123M